PharmaCielo Ltd.
PCLOF
$0.0478
-$0.0067-12.29%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.51% | 8.57% | 2.42% | -7.98% | 22.61% |
| Total Depreciation and Amortization | -30.24% | 215.47% | 40.61% | 120.56% | -53.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.20% | 8.77% | 7.98% | 27.48% | 24.48% |
| Change in Net Operating Assets | 1,029.85% | 33.00% | 198.89% | 209.37% | 103.79% |
| Cash from Operations | 40.89% | 43.82% | 38.30% | 48.49% | 61.26% |
| Capital Expenditure | 92.70% | 98.56% | 99.35% | 97.18% | 92.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -56.26% | -42.32% | 115.71% | 1,130.58% | 287.84% |
| Cash from Investing | -51.40% | 96.27% | 224.66% | 193.51% | 142.94% |
| Total Debt Issued | -46.21% | -38.91% | -36.68% | -6.04% | -43.55% |
| Total Debt Repaid | -19.44% | -16.16% | -47.52% | -31.30% | -45.35% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -100.00% | 492.50% | -- | 854.72% |
| Cash from Financing | -34.79% | -39.86% | -42.05% | -15.58% | -51.65% |
| Foreign Exchange rate Adjustments | 149.02% | 150.34% | 163.64% | 167.63% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.74% | 93.07% | 71.39% | 97.92% | 93.24% |
